- What is ADCETRIS (brentuximab vedotin)?
- How does ADCETRIS plus AVD work differently than traditional chemotherapy?
- Why may ADCETRIS be an effective treatment option for me?
- What are the benefits and risks of ADCETRIS?
- How does ADCETRIS help treat my cancer?
- Can you explain the clinical trial results for ADCETRIS?
- Will ADCETRIS interfere with other medications that I am currently taking?
- How is ADCETRIS given?
- How long will I take ADCETRIS?
- How often will I have appointments with my healthcare team?
- Are there other medications I should take with ADCETRIS?
- How will treatment interrupt my day-to-day life? Can I keep working or going to school?
- How much time does the infusion take?
- Will I need recovery time after the infusion?
- What tests will you do to see if the treatment is working?
- What are the possible risks and side effects of ADCETRIS?
- What are the most common side effects seen with ADCETRIS?
- What are my chances of getting a serious side effect like progressive multifocal leukoencephalopathy?
- What is the most important safety information I should know about ADCETRIS?
- Will I lose my hair while on ADCETRIS?
- Will I need to stop medication if I have side effects?
- What should I do if I experience a side effect?
- Will treatment affect my fertility?
- What can I do to preserve my fertility?
- How long will my partner and I need to prevent pregnancy while taking ADCETRIS?
- How long should we wait to try to get pregnant after treatment has ended?
- What if I can’t afford my ADCETRIS treatment?
- Where can I find information about paying for my treatment and other related expenses?
- What other support services are available?
- How can I connect with other people like me who have had treatment, or who are currently being treated with ADCETRIS?
The Treatment Decision Guide can also help you learn about treatment options and think through your next conversation with your doctor.
Glossary
ABVD: A combination of 4 chemotherapies—Adriamycin, bleomycin, vinblastine, and dacarbazine.